Drafting and Negotiating Clinical Trial Agreements Back
Clinical trial agreements are one of the most important agreements in the pharma industry as no research can start without the right agreement in place between sponsor and host organisation. They provide a contract which manages the relationship and responsibilities of both parties, and provide for the allocation of risk, obligations, the protection of academia, terms of collaboration, IP rights and much more.
This intensive one-day programme, delivered by experts in the field, will provide you with a full understanding of the importance of CTAs. It will describe how the regulatory environment affects them and explain the typical clauses which make up a CTA and what the key differences are between European and the US. By the end of this seminar you will be confident in spotting and addressing issues which arise when negotiating and drafting clinical trial agreements.
Who should attend?
- Contract managers
- Clinical contract specialists
- Clinical trial managers
- R&D staff
- Regulatory specialists
- Legal executives
Short courses (CPD) - Full time
- Start date:
- 15 May 2018
- 1 Day
- Teaching method: